However, we cautiously hypothesize that the tumorigenic properties of ERp46 in RCC cells may not be related to an inhibitory modulation of adiponectin's tumor-suppressive signaling, as an interaction with AdipoR1 could not be established. Here, ADIPOQ is linked to neoplasm.